产品展示
A0056 C/EBP-alpha (Phospho-Ser21) Antibody
点击次数：143发布时间：2012/8/23 15:40:31
更新日期：2024/10/16 15:59:07
所 在 地：美洲
产品型号：
优质供应
详细内容
慧嘉生物您实验身边的好伙伴
为客户提供“品质的产品”和“*优质的服务”
AssayBiotech CUSABIO Immunoway Santa Abcam Cst jackson Pierce Sigma Amresco Qiagen Cayman abnova millipore invitrogen ebioscience prospec
欢迎广大客户咨询，另有大量宣传海报和小礼品赠送。
联系电话：
传 真：
Q Q：1193953234 1048735792
邮 箱：sale@biohj.com
A0056 C/EBP-alpha （Phospho-Ser21） Antibody
| Reactivity | Applications | MW. | Source |
| H, M, R | WB IHC ELISA | 37 kDa | Rabbit |
Note: The product is for research use only, not for use in diagnostic or therapeutic procedures.
| Product Name | C/EBP-alpha （Phospho-Ser21） Antibody |
| Synonyms | C/EBP alpha; CCAAT/enhancer binding protein （C/EBP）, alpha; CCAAT/enhancer binding protein alpha; CEBPA |
| Immunogen | The antiserum was produced against synthesized peptide derived from human C/EBP-alpha around the phosphorylation site of Ser21. |
| Immunogen Region | N-terminal |
| Clonality | Polyclonal |
| Modification sites | H:S21 M:S21 R:S21 |
| Application dilutions | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:1000 |
| Specificity | C/EBP-alpha （Phospho-Ser21） Antibody detects endogenous levels of C/EBP-alpha only when phosphorylated at serine21. |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation. |
| Physical Form | Rabbit IgG in phosphate buffered saline （without Mg2+ ａnd Ca2+）, pH 7.4, 150mM NaCl, 0.02% sodium azide ａnd 50% glycerol. |
| Concentration | 1 mg/ml |
| Storage/Stability | Store at -20℃/1 year |
| NCBI Gene Symbol | CEBPA | ||||||||
| Database Links |
| ||||||||
| Application images |  Immunohistochemistry analysis of paraffin-embedded human lung carcinoma, using C/EBP-alpha （Phospho-Ser21） Antibody. The picture on the right is treated with the synthesized peptide.  Western blot analysis of extracts from HepG2 cells treated with EGF 200ng/ml 5＇, using C/EBP-alpha （Phospho-Ser21） Antibody. The lane on the right is treated with the synthesized peptide. |
